INOTIV INC (NOTV)
US45783Q1004 - Common Stock
Overall NOTV gets a fundamental rating of 3 out of 10. We evaluated NOTV against 59 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of NOTV have multiple concerns. NOTV is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year NOTV has reported negative net income.
In the past year NOTV had a positive cash flow from operations.
NOTV had negative earnings in 4 of the past 5 years.
Of the past 5 years NOTV 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of NOTV (-3.98%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -13.08%, NOTV is in line with its industry, outperforming 52.54% of the companies in the same industry.
NOTV has a better Return On Invested Capital (0.68%) than 62.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.98% | ||
| ROE | -13.08% | ||
| ROIC | 0.68% |
ROA(3y)-14.63%
ROA(5y)-10.68%
ROE(3y)-40.73%
ROE(5y)-38.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NOTV has a Operating Margin of 1.07%. This is in the better half of the industry: NOTV outperforms 62.71% of its industry peers.
Looking at the Gross Margin, with a value of 30.27%, NOTV is doing worse than 72.88% of the companies in the same industry.
NOTV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.07% | ||
| PM (TTM) | N/A | ||
| GM | 30.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.33%
GM growth 5Y-1.26%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NOTV is destroying value.
The number of shares outstanding for NOTV has been increased compared to 1 year ago.
NOTV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NOTV is higher compared to a year ago.
2.2 Solvency
NOTV has an Altman-Z score of 0.18. This is a bad value and indicates that NOTV is not financially healthy and even has some risk of bankruptcy.
NOTV's Altman-Z score of 0.18 is on the low side compared to the rest of the industry. NOTV is outperformed by 69.49% of its industry peers.
The Debt to FCF ratio of NOTV is 67.58, which is on the high side as it means it would take NOTV, 67.58 years of fcf income to pay off all of its debts.
NOTV has a Debt to FCF ratio of 67.58. This is comparable to the rest of the industry: NOTV outperforms 55.93% of its industry peers.
NOTV has a Debt/Equity ratio of 1.46. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.46, NOTV is doing worse than 86.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.46 | ||
| Debt/FCF | 67.58 | ||
| Altman-Z | 0.18 |
ROIC/WACC0.07
WACC9.66%
2.3 Liquidity
NOTV has a Current Ratio of 1.74. This is a normal value and indicates that NOTV is financially healthy and should not expect problems in meeting its short term obligations.
NOTV's Current ratio of 1.74 is on the low side compared to the rest of the industry. NOTV is outperformed by 72.88% of its industry peers.
A Quick Ratio of 1.28 indicates that NOTV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.28, NOTV is doing worse than 77.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
NOTV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.92%, which is quite impressive.
The Revenue has decreased by -0.18% in the past year.
The Revenue has been growing by 85.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)66.92%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q82.4%
Revenue 1Y (TTM)-0.18%
Revenue growth 3Y111.51%
Revenue growth 5Y85.16%
Revenue growth Q2Q10.34%
3.2 Future
Based on estimates for the next years, NOTV will show a very strong growth in Earnings Per Share. The EPS will grow by 31.79% on average per year.
NOTV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.31% yearly.
EPS Next Y71.46%
EPS Next 2Y31.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.71%
Revenue Next 2Y2.66%
Revenue Next 3Y5.93%
Revenue Next 5Y8.31%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTV. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NOTV indicates a rather cheap valuation: NOTV is cheaper than 100.00% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, NOTV is valued cheaper than 96.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.71 | ||
| EV/EBITDA | 7.71 |
4.3 Compensation for Growth
NOTV's earnings are expected to grow with 31.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.79%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NOTV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INOTIV INC
NASDAQ:NOTV (4/25/2024, 5:19:45 PM)
After market: 4.23 -0.06 (-1.4%)4.29
-0.38 (-8.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap110.64M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.98% | ||
| ROE | -13.08% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 1.07% | ||
| PM (TTM) | N/A | ||
| GM | 30.27% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.46 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.74 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)66.92%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y71.46%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.18%
Revenue growth 3Y111.51%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y